FDA Classifies 12 Ventec Ventilator Records as Class I Recall in October 2026: Flow Sensor Cable May Detach and Cause Restart

Published: 2026-10-22 09:31 | Category: Recall and Safety Notices

On October 20, 2026, the U.S. Food and Drug Administration (FDA) published 12 Class I recall records in its medical device recall database. All 12 records point to the same company and the same component issue: ventilators in the VOCSN, VOCSN+Pro, VC, VC+Pro, V+Pro, VCSN+Pro and V*Home series manufactured by Ventec Life Systems, Inc. The internal flow sensor cable connector may detach from the mainboard, which may cause the system to restart and interrupt ventilation therapy.

The 12 records belong to one recall event, event number 99835. The company-initiated recall date is September 17, 2026; FDA completed classification and publication on October 20, 2026. Records are separated by model and market. The U.S. and Japan versions have separate recall numbers, numbered from Z-0122-2027 to Z-0133-2027.

Failure Point: Cable Connector

FDA records state the cause as follows: the cable connector of the internal flow sensor may detach from the internal circuit board, which may cause a system restart and thereby interrupt ventilation therapy. This type of failure does not require total device failure. A single restart is enough to deprive a patient who is relying on ventilatory support of therapy, including in the home, nursing facility, and transport settings.

FDA marks the cause determination as 'under company investigation.' This means that the responsibility determination has not been concluded and the record content may be updated later. The company initiated the recall on September 17, and FDA published it on October 20. The period of more than one month in between reflects the normal pace of recall classification and review; it does not mean that the problem was discovered only in October.

Product Lines and Quantities

The product lines involved are VOCSN, VOCSN+Pro, VC, VC+Pro, V+Pro, VCSN+Pro, V*Home, and corresponding models for the Japanese market. The product code is CBK (continuous ventilator, institutional use), and the associated premarket authorization is K162877.

Quantities are counted by model and are not combined. For the two records checked for this article:

• VOCSN+Pro (model PRT-00490-001; package part number PRT-00853-000): 4,369 units, covering all serial numbers; UDI 00855573007792 and 00855573007006.
• VC+Pro (model PRT-00900-001; package part number PRT-00973-000): 1,534 units, also covering all serial numbers.

Both records state that distribution was nationwide in the United States, including Puerto Rico. Japan versions are listed in separate records. Their quantities must be checked on the respective record pages and cannot be directly based on the U.S. numbers.

What the Company Requires Recipients to Do

On September 17, 2026, Ventec Life Systems (doing business as React Health) issued an 'URGENT: Medical Device Recall Notification' by registered mail. Recipients are required to do three things:

• Follow the 'Actions to Be Taken' section in the notification.
• Confirm receipt within 7 days using the reply form, by email, by mail, or through the company's online form.
• If the device has been transferred to another facility, caregiver, or end user, immediately notify that party and provide a copy of the notification.

The public database does not set out the specific corrective action details, such as whether the harness will be replaced, the connection reinforced, or the whole unit repaired. To determine how to handle a device in hand, refer to the customer communication materials enclosed with the company letter or contact the React Health service telephone number listed in the record.

Weight of a Class I Recall

FDA defines a Class I recall as a situation in which there is a reasonable probability that use of the device will cause serious injury or death. This level describes the nature of the risk, not the number of incidents that have occurred. None of the 12 records lists injury or death associated with this issue. This does not mean that no cases exist; it means only that the public records do not provide them.

The record status is 'Open, Classified.' This means the company has initiated the recall, but the product has not been fully corrected or removed. The database will be updated as progress is made. Queries and tracking should rely on the summary page for event number 99835; an individual record page reflects only the current status of that model.

Why This Is Worth Watching for Manufacturers

Ventilators are one of the few product categories where a failure can immediately affect life. In this case, the failure point is the connector of an internal cable. It does not involve an algorithm or software logic; it is a mechanical connection and assembly-process issue. Such issues often occupy only a short section in registration materials, yet in real-world use they determine whether a device can operate continuously.

AIMEILI Regulatory Interpretation

This recall is a useful regulatory signal because a small mechanical interface led to a Class I field action. For regulatory affairs teams, the key points are:

• Class I risk is based on the nature of the failure, not on confirmed harm. A restart during ventilation support can interrupt therapy, so FDA classified the event at the highest level even though the public records do not list injury or death.
• Field action timing is separate from database publication. The company initiated the recall on September 17, 2026; FDA published the classified records on October 20, 2026. The gap is normal and does not indicate delayed discovery.
• Traceability must be model-, part-, UDI- and serial-number-specific. The records separate models and markets, and Japan records must be checked separately. U.S. quantities cannot be applied to other markets.
• Recipient acknowledgement and downstream notification are core recall controls. The 7-day receipt confirmation and transfer notification requirements are practical elements that regulators expect to see documented.
• 'Open, Classified' status requires continued monitoring. The corrective action is not complete, and the event summary page for 99835 should be tracked for updates.

AIMEILI's interpretation is that manufacturers should treat connector reliability as a design and process-control issue, not merely a supplier or incoming-inspection issue. Design verification, process validation, assembly controls, and post-market surveillance should be linked when assessing similar risks.

Business Impact

For global manufacturers, distributors, CROs and regulatory affairs teams, the business impact includes:

• Inventory and distribution controls: Distributors should identify affected models, part numbers, UDI and serial numbers, quarantine affected inventory, and document customer notification and acknowledgement.
• Post-market surveillance and CAPA: Manufacturers should review comparable cable-connector designs, assembly processes, supplier controls, and complaint trends; update risk analysis and CAPA records where needed.
• Regulatory reporting readiness: Teams should maintain recall SOPs, communication templates, traceability records, and timelines for authority reporting and field action execution.
• Registration and tender impact: A Class I recall can affect hospital confidence, tender eligibility, and registration maintenance. Regulatory teams should be prepared to respond to authority and customer inquiries with accurate scope and corrective-action information.
• CRO and study support: Where affected ventilators are used in clinical studies or post-market studies, CROs should assess notification obligations, site communication, and device accountability records.

Sources and Applicability

Sources: U.S. Food and Drug Administration (FDA) Medical Device Recall Database, VOCSN+Pro recall record Z-0122-2027, published 2026-10-20: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=222675

Summary page for the same event, event number 99835, 12 records in total: https://www.accessdata.fda.gov/scripts/cdrh/cfRES/res.cfm?start_search=1&event_id=99835

VC+Pro recall record Z-0124-2027, published 2026-10-20: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=222677

Verification scope and access date: The FDA database pages above were accessed on October 22, 2026. The review checked the record count on the event summary page; the initiation date, publication date, recall number, model and part number, UDI, distribution scope, quantity, cause statement, and required actions for the two single-model records. For the remaining model records, only existence and recall numbers were confirmed; not all fields were extracted.

Applicability: This article summarizes and interprets FDA public recall information. It does not constitute a compliance conclusion or commitment for any specific product, company, or registration application. Recall records may be updated as company investigations and FDA reviews proceed; the official original text prevails.

Information sources: U.S. FDA Medical Device Recall Database (VOCSN+Pro, Z-0122-2027), 2026-10-20; U.S. FDA Medical Device Recall Database (event 99835 summary), 2026-10-20; U.S. FDA Medical Device Recall Database (VC+Pro, Z-0124-2027), 2026-10-20.